Atovaquone Suspension
Product Images NDC 81033-104

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 81033-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kesin Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 81033-104-05 (Ndc 81033 104 05)

Atovaquone oral suspension unit dose, 750 mg per 5 mL, in a single-use plastic container. The label includes storage instructions, barcode, NDC 81033-104-05, package by Kesin Pharma, Oldsmar, FL, and indicates sugar-free formulation for institutional use only.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of the active ingredient Atovaquone, showing its molecular framework including a chlorophenyl group and quinone moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.